N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44% Market Closed
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note

Operating Margin
NewGLab Pharma Co Ltd

-193.8%
Current
-129%
Average
4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-193.8%
=
Operating Profit
-11.8B
/
Revenue
6.1B

Operating Margin Across Competitors

Country KR
Market Cap 323.6B KRW
Operating Margin
-194%
Country JP
Market Cap 15.6T JPY
Operating Margin
51%
Country CN
Market Cap 288.1B CNY
Operating Margin
16%
Country US
Market Cap 28.2B USD
Operating Margin
17%
Country SE
Market Cap 283.3B SEK
Operating Margin
26%
Country US
Market Cap 21.9B USD
Operating Margin
18%
Country US
Market Cap 20.3B USD
Operating Margin
14%
Country US
Market Cap 17.5B USD
Operating Margin
12%
Country IL
Market Cap 14.2B USD
Operating Margin
-21%
Country UK
Market Cap 10.3B GBP
Operating Margin
18%
Country JP
Market Cap 1.3T JPY
Operating Margin
13%
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
323.6B KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
84.39 KRW
Overvaluation 99%
Intrinsic Value
Price
N

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-193.8%
=
Operating Profit
-11.8B
/
Revenue
6.1B
What is the Operating Margin of NewGLab Pharma Co Ltd?

Based on NewGLab Pharma Co Ltd's most recent financial statements, the company has Operating Margin of -193.8%.